Filing Flows › Organon (OGN) › Q2 2026 › vs Q1 2026
Organon (OGN) Q2 2026 vs Q1 2026 (quarter over quarter)
Organon's revenue rose $98.0M (+7%) from $1.5B in Q1 2026 to $1.6B in Q2 2026. Gross margin 54.4% against 53.6% (+0.7 pts).
Organon, Q2 2026: revenue $1.6B (-2% year over year), operating margin 11.7%, net earnings $108M, operating cash flow $107M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 54.4% | 53.6% | +0.7 pts |
| Operating margin | 11.7% | 14.6% | -2.8 pts |
| Net margin | 6.9% | 10.0% | -3.1 pts |
| Free cash flow margin | 4.2% | 12.9% | -8.7 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $98.0M | +7% |
| Gross profit | $847M | $783M | $64.0M | +8% |
| Cost of revenue | $711M | $677M | $34.0M | +5% |
| Operating profit | $183M | $213M | −$30.0M | -14% |
| Operating expenses | $664M | $570M | $94.0M | +16% |
| Pre-tax earnings | $183M | $213M | −$30.0M | -14% |
| Research & development | $90.0M | $93.0M | −$3.0M | -3% |
| SG&A | $434M | $424M | $10.0M | +2% |
| Other operating costs | $140M | $53.0M | $87.0M | +164% |
| Net earnings | $108M | $146M | −$38.0M | -26% |
| Income tax | $75.0M | $67.0M | $8.0M | +12% |
| Depreciation | $34.0M | $39.0M | −$5.0M | -13% |
| Share-based compensation | $25.0M | $19.0M | $6.0M | +32% |
| Working capital & other | $60.0M | −$21.0M | $81.0M | — |
| Operating cash flow | $107M | $225M | −$118M | -52% |
| Free cash flow (OCF − capex) | $65.0M | $188M | −$123M | -65% |
| Capital expenditures | $42.0M | $37.0M | $5.0M | +14% |
Questions
How much did Organon's revenue grow quarter over quarter in Q2 2026?
Organon's revenue rose $98.0M (+7%) from $1.5B in Q1 2026 to $1.6B in Q2 2026. Gross margin 54.4% against 53.6% (+0.7 pts).